Cargando…

Methotrexate Induced Lung Injury in a Patient with Primary CNS Lymphoma: a Case Report

Methotrexate is an antimetabolite commonly used in clinical practice for a variety of indications ranging from rheumatoid arthritis and other connective tissue disorders to high dose regimens in many malignancies. This folate antagonist has got a spectrum of toxicities among which gastrointestinal e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chhabra, Puneet, Law, Arjun Dutt, Suri, Vikas, Malhotra, Pankaj, Varma, Subhash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2012
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340991/ https://www.ncbi.nlm.nih.gov/pubmed/22550565 http://dx.doi.org/10.4084/MJHID.2012.020

Ejemplares similares

Crystalline Nephropathy With High-Dose Methotrexate in a Patient With Primary CNS Lymphoma: A Case Report
por: Sami, Faria Latif, et al.
Publicado: (2022)

A young man with acute respiratory distress syndrome: eosinophilia is not always “benign”
por: Jain, Ankur, et al.
Publicado: (2017)

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas
por: Ferreri, A J M, et al.
Publicado: (2004)

Primary CNS Lymphoma
por: Phillips, Elizabeth H., et al.
Publicado: (2014)

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
por: Fritsch, K, et al.
Publicado: (2017)

ML-08 THE ROLE OF MAINTENANCE HIGH-DOSE METHOTREXATE CHEMOTHERAPY IN ELDERLY PRIMARY CNS LYMPHOMA PATIENTS
por: Mishima, Kazuhiko, et al.
Publicado: (2019)

Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy
por: Kebir, Sied, et al.
Publicado: (2012)

An audit on the diagnosis of primary CNS lymphoma
por: Joe, Dorothy, et al.
Publicado: (2021)

Primary CNS Lymphoma Masquerading as Ventriculitis
por: Rohatgi, Shalesh, et al.
Publicado: (2022)

Incorporating Cystatin C to Predict Methotrexate Elimination in Patients with CNS Lymphoma and Suspicious Renal Function
por: Barreto, Jason N., et al.
Publicado: (2018)

A short report on chronic myeloid leukemia from Post Graduate Institute of Medical Education and Research, Chandigarh
por: Malhotra, Pankaj, et al.
Publicado: (2013)

Preventive role of carvedilol in adriamycin-induced cardiomyopathy
por: Jhorawat, Rajesh, et al.
Publicado: (2016)

Fluoro-deoxy-glucose positron emission tomography/computed tomography in lymphoma: A pictorial essay
por: Manohar, Kuruva, et al.
Publicado: (2013)

P1160: METHOTREXATE IN COMBINATION WITH IBRUTINIB, THIOTEPA, RITUXIMAB (R-MTO) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANT FOR PRIMARY CNS LYMPHOMA
por: Xing, LI-Jie, et al.
Publicado: (2023)

High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma
por: Ong, Shin Yeu, et al.
Publicado: (2021)

Unilateral Primary Adrenal Lymphoma: Uncommon Presentation of a Rare Disease Evaluated Using (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
por: Radhakrishnan, Renjith Kalathoorakathu, et al.
Publicado: (2018)

Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
por: Prodduturi, Prathima, et al.
Publicado: (2012)

Relapse pattern and prognosis of primary CNS lymphoma
por: Dahiya, Saurabh, et al.
Publicado: (2012)

Expression of Tim‐1 in primary CNS lymphoma
por: Kishimoto, Wataru, et al.
Publicado: (2016)

Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring
por: Chiavazza, C., et al.
Publicado: (2018)

Sex-Specific Differences in Primary CNS Lymphoma
por: Roetzer, Thomas, et al.
Publicado: (2020)

Update on Novel Therapeutics for Primary CNS Lymphoma
por: Schaff, Lauren R., et al.
Publicado: (2021)

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy
por: Sheu, Tommy, et al.
Publicado: (2018)

High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials
por: Yu, Junyao, et al.
Publicado: (2021)

R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement
por: Steinhardt, Maximilian J., et al.
Publicado: (2021)

Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort
por: Yerram, Prakirthi, et al.
Publicado: (2023)

Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS
por: Nagle, Sarah J, et al.
Publicado: (2017)

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
por: Bobillo, Sabela, et al.
Publicado: (2021)

CD 5+ Peripheral B Cell Lymphoma With Transformation to CD 5+ Diffuse Large B Cell Lymphoma in the CNS: A Case Report Treated With Rituximab, High Dose Methotrexate, Cytarabine, and Intrathecal Methotrexate
por: Uczkowski, Dariusz, et al.
Publicado: (2022)

One minute sit-to-stand test as a potential triage marker in COVID-19 patients: A pilot observational study
por: Guha Niyogi, Subhrashis, et al.
Publicado: (2021)

Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial
por: Joerger, M, et al.
Publicado: (2010)

Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial
por: Wu, Jingjing, et al.
Publicado: (2018)

Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
por: Seidel, Clemens, et al.
Publicado: (2021)

Multiparametric MR Imaging Features of Primary CNS Lymphomas
por: Talybov, Rustam, et al.
Publicado: (2022)

Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
por: Heming, Michael, et al.
Publicado: (2022)

IL-4 CHALLENGES FOR MANAGEMENT OF PRIMARY CNS LYMPHOMA
por: Nagane, Motoo
Publicado: (2022)

PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS.
por: Misyurina, A., et al.
Publicado: (2022)

NQPC-5 Does high-dose methotrexate-based chemotherapy for relapsed primary CNS lymphoma increase a risk of leukoencephalopathy with prior whole brain radiotherapy?
por: Kobayashi, Keiichi, et al.
Publicado: (2021)

Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C
por: Mishima, Kazuhiko, et al.
Publicado: (2022)

Shoulder pain: a hematologist’s perspective
por: Jain, Ankur, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_msc24t1ie1d7vas5fk56m82m3g